Avoro Capital Advisors’s Oncobiologics, Inc. Series A Warrant Expiring 2/18/2019 ONSIW Stock Holding History

Avoro Capital Advisors’s Portfolio ONSIW Stock Details ONSIW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-233,333	Closed	-$3K	–	51
2018 Q3	$3K	Hold	233,333	–	–	﹤0.01%	45
2018 Q2	$12K	Hold	233,333	–	–	﹤0.01%	42
2018 Q1	$5K	Hold	233,333	–	–	﹤0.01%	56
2017 Q4	$7K	Hold	233,333	–	–	﹤0.01%	49
2017 Q3	$28K	Hold	233,333	–	–	﹤0.01%	42
2017 Q2	$40K	Hold	233,333	–	–	0.01%	45
2017 Q1	$187K	Hold	233,333	–	–	0.02%	44
2016 Q4	$44K	Hold	233,333	–	–	0.01%	41
2016 Q3	$112K	Hold	233,333	–	–	0.02%	46
2016 Q2	$107K	Buy	+233,333	New	+$89.3K	0.02%	39

Avoro Capital Advisors's ONSIW Position: Q4 2018 in Review

Avoro Capital Advisors sold out of Oncobiologics, Inc. Series A Warrant Expiring 2/18/2019 (ONSIW) in Q4 2018, closing a stake of 233,333 shares — an estimated $3K sold.

Avoro Capital Advisors first reported a position in ONSIW in Q2 2016 and held it in 10 quarters. The position peaked at $187K in Q1 2017. 0 funds tracked by Wall St. Rank hold ONSIW as of Q4 2018.

Avoro Capital Advisors reported no remaining Oncobiologics, Inc. Series A Warrant Expiring 2/18/2019 position as of Q4 2018 after selling out during the quarter.
Avoro Capital Advisors sold 233,333 Oncobiologics, Inc. Series A Warrant Expiring 2/18/2019 shares in Q4 2018, an estimated $3K.
Avoro Capital Advisors first reported a position in Oncobiologics, Inc. Series A Warrant Expiring 2/18/2019 in Q2 2016 and held it in 10 quarters.
Avoro Capital Advisors's Oncobiologics, Inc. Series A Warrant Expiring 2/18/2019 position peaked at $187K in Q1 2017.
0 funds tracked by Wall St. Rank held Oncobiologics, Inc. Series A Warrant Expiring 2/18/2019 as of Q4 2018.

Based on Avoro Capital Advisors's 13F filing for Q4 2018, filed 14 Feb 2019.